Dbv Technologies Sa-spon Adr (DBVT) Smart Money Holdings (13F, Q2 2026)

DBVT ranks #5142 out of 37501 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

78 institutions disclose a position in DBVT, but none treat it as a major bet — even MPM BioImpact LLC, its most concentrated holder, allocates just 3.7% of its own portfolio to it.

Morgan Stanley has added to its DBVT position for two straight quarters, increasing it by $13.3M to reach $15.7M today.

Artisan Partners Limited Partnership has trimmed its DBVT position for two straight quarters, cutting it by $40.9M while still holding $22.5M.

DBVT is up 1.4% today, and institutions have been net buyers of $14.6M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

DBVT reported a net loss of $176.0M over the trailing twelve months.

• Not yet profitable — net loss of $176.0M over the trailing twelve months
• Revenue grew 29.3% year over year
• Net income declined year over year, from -$122.5M to -$176.0M
• Operating cash flow was negative, using $121.2M in cash
• Current ratio of 3.67x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.38x equity — within a conventional range